Matrix Metalloproteinase-Targeted Imaging of Lung Inflammation and Remodeling.
Matrix Metalloproteinase-Targeted Imaging of Lung Inflammation and Remodeling.
复制标题
DOI:
10.2967/jnumed.116.176198
复制
发表时间:
2017-01
期刊:
影响因子:
--
通讯作者:
Sadeghi MM
中科院分区:
文献类型:
--
作者:
Golestani R;Razavian M;Ye Y;Zhang J;Jung JJ;Toczek J;Gona K;Kim HY;Elias JA;Lee CG;Homer RJ;Sadeghi MM
Imaging techniques for detection of molecular and cellular processes that precede or accompany lung diseases are needed. Matrix metalloproteinases (MMPs) play key roles in the development of pulmonary pathology. Investigate the feasibility of in vivo MMP-targeted molecular imaging for detection of lung inflammation and remodeling. Lung-specific IL-13 transgenic [Club cell 10-kDa protein (CC10)-IL-13Tg)] mice, and wild type (WT) littermates were used in this study. Lung structure, gene expression, and MMP activity were assessed by histology, real-time reverse transcription polymerase chain reaction, Western blot and zymography. MMP activation was imaged by in vivo micro single-photon emission computed tomography (SPECT)/CT followed by ex vivo planar imaging. Signal specificity was addressed using a control tracer. The correlation between in vivo MMP signal and gene expression was addressed. CC10-IL-13Tg mice developed considerable pulmonary tissue remodeling and inflammation. CD68, MMP-12 and MMP-13 were significantly higher in CC10-IL-13Tg lungs. On in vivo microSPECT/CT and ex vivo planar images, the MMP signal was significantly higher in the lungs of CC10-IL-13Tg mice than WT animals. Furthermore, a non-binding analog tracer showed significantly lower accumulation in CC10-IL-13Tg lungs relative to the specific tracer. There was a significant correlation between microSPECT/CT-derived MMP signal and CD68 expression in the lungs (r = 0.70, P < 0.01). MicroSPECT/CT-based MMP-targeted imaging of the lungs is feasible and reflects pulmonary inflammation. If validated in humans, molecular imaging of inflammation and remodeling can potentially help early diagnosis and monitoring of the effects of therapeutic interventions in pulmonary diseases.
登录
查看更多内容
DOI:
10.2967/jnumed.114.152355
发表时间:
2015-06
期刊:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子:
--
作者:
Jung JJ;Razavian M;Challa AA;Nie L;Golestani R;Zhang J;Ye Y;Russell KS;Robinson SP;Heistad DD;Sadeghi MM
通讯作者:
Sadeghi MM
影响因子:
5.8
作者:
Hersh CP;Washko GR;Estépar RS;Lutz S;Friedman PJ;Han MK;Hokanson JE;Judy PF;Lynch DA;Make BJ;Marchetti N;Newell JD Jr;Sciurba FC;Crapo JD;Silverman EK;COPDGene Investigators
通讯作者:
COPDGene Investigators
影响因子:
4.8
作者:
Devel, L;Rogakos, V;Dive, V
通讯作者:
Dive, V
影响因子:
15.9
作者:
Lanone, S;Zheng, T;Elias, JA
通讯作者:
Elias, JA
DOI:
10.1084/jem.194.6.809
发表时间:
2001-09-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Lee CG;Homer RJ;Zhu Z;Lanone S;Wang X;Koteliansky V;Shipley JM;Gotwals P;Noble P;Chen Q;Senior RM;Elias JA
通讯作者:
Elias JA